Table 1 Summary statistics for targeted viruses and sequencing results
Virus type | Forward success rate (%) | Reverse success rate (%) | Average success rate (%) | Number of reactions successful | Number of reactions total | Ambiguity in consensus (%) | GC content of consensus sequence (%) | Number of sequences in consensus | Number of amplicons designed | Minimum coverage | BioProject ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
HPIV-1 | 98.95 | 100.00 | 99.47 | 378 | 380 | 5.10 | 34.64 | 5 | 95 | 3x | PRJNA73053 |
HPIV-3 | 98.42 | 97.89 | 98.16 | 373 | 380 | 7.77 | 31.24 | 5 | 95 | 3x | PRJNA73055 |
MeV | 93.41 | 95.05 | 94.23 | 1738 | 1860 | 10.76 | 41.94 | 25 | 91 | 3x | PRJNA69913 |
MuV | 73.85 | 73.68 | 73.77 | 1963 | 2661 | 9.28 | 37.97 | 32 | 96 | 3x | PRJNA73019 |
RUBV-G1 | 80.05 | 78.63 | 79.34 | 3556 | 4882 | 6.07 | 66.75 | 11 | 96 | 2x | PRJNA70479 |
RUBV-G2 | 71.52 | 69.24 | 70.38 | 1478 | 2100 | 13.13 | 61.37 | 5 | 96 | 2x | PRJNA70479 |
HRSV-A | 91.32 | 89.96 | 90.64 | 3004 | 3332 | 6.81 | 30.25 | 3 | 50 | 2x | PRJNA73049 |
HRSV-B | 91.37 | 90.86 | 91.11 | 2436 | 2682 | 4.12 | 31.79 | 3 | 59 | 2x | PRJNA73049 |
HMPV-A | 90.99 | 88.82 | 89.91 | 1737 | 1932 | 9.25 | 31.53 | 6 | 42 | 1x | PRJNA73051 |
HMPV-B | 86.16 | 87.04 | 86.60 | 788 | 910 | 7.95 | 32.68 | 5 | 36 | 1x | PRJNA73051 |